Hillsdale Investment Management Inc. Simulations Plus, Inc. Transaction History

Hillsdale Investment Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$53.26 - $77.18 $2.21 Million - $3.2 Million	-41,438 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$57.51 - $75.36 $1.05 Million - $1.37 Million	18,200 Added 78.32%	41,438 $3.12 Million
Q2 2020 Aug 11, 2020	BUY	$32.91 - $59.82 $13,163 - $23,928	400 Added 1.75%	23,238 $1.39 Million
Q1 2020 May 12, 2020	BUY	$26.79 - $38.99 $80,370 - $116,970	3,000 Added 15.12%	22,838 $797,000
Q4 2019 Feb 12, 2020	SELL	$29.07 - $35.63 $595,935 - $730,415	-20,500 Reduced 50.82%	19,838 $576,000
Q3 2019 Nov 13, 2019	BUY	$28.19 - $41.75 $1.14 Million - $1.68 Million	40,338 New	40,338 $1.4 Million
Q3 2018 Nov 09, 2018	SELL	$17.1 - $23.55 $13,680 - $18,840	-800 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$14.65 - $23.75 $11,720 - $19,000	800 New	800 $18,000

179

15.9M

3.9K

200

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $626M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.